FDA Approves First Treatment for Rett Syndrome
Approval of Daybue applies to adults and children aged 2 years and older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Approval of Daybue applies to adults and children aged 2 years and older
Only registered members have full access to PracticeUpdate content.